Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

5/28/2020 Ranking of Russian Pharmacy Chains Q1 2020

The pharmaceutical market is actively preparing for a drop in demand at the moment. At best, the retail dynamics will hardly go beyond stagnation by the end of the year, even though March turned out to be busy. With the stocks replenished during the hype being used now, the consumption curve is already noticeably lower than it usually is at this time of year.

5/27/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 17% of Doctors Say They Have Witnessed Manipulation of Data on COVID-19 Deaths

While 61% of Russian doctors question the official COVID-19 death rate in Russia, they do not have evidence of the statistics being manipulated, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Obviously, this reflects both a general distrust of the statistical service in the healthcare system, and purely methodological issues, such as a large number of people who did not experience any symptoms, the quality of the tests and collection of biological materials, etc.

5/27/2020 Pharmaceutical Drug Production in Russia (April 2020)

Between January and April 2020, Russia manufactured 150 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is in monetary terms (rubles) 17.7% higher than in 2019. The dynamics in physical terms (units) are +6.6%, thanks to the high activity in March and April.

5/21/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 92% of Doctors Report Decreasing Access to Medical Care due to COVID-19

52% of doctors say that access to medical care has worsened after the outbreak of the coronavirus epidemic, because anything not related to COVID-19 now works on the residual principle, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 40% believe that the situation is close to critical, because doctors are overloaded, and many healthcare facilities are being re-profiled, while the retired capacities are not compensated in any way. It is mostly the doctors from Moscow and St. Petersburg who consider the situation critical. This correlates with the morbidity statistics, at the time of the survey Moscow accounted for more than 50% of all COVID-19 cases.

5/21/2020 Ranking of Russian Pharmaceutical Distributors (Q1 2020)

It is unlikely that the Russian pharmaceutical market players that launched various anti-crisis programs a couple of years ago could have guessed that early 2020 would shock them with the coronavirus, rush demand and desperate regulatory activity. While they could feel a crisis approaching, they were still preparing for something else.

5/19/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (April 2020)

Between January and April 2020, the sales of veterinary drugs in the retail market amounted to 6.9 bln RUB (retail prices, VAT included), with the dynamics in monetary terms (rubles) of +0.6%. In comparison with the Q1 dynamics (+20.4%), the dynamics in April seem twice as modest. If calculated in minimum dosage units (MDU), the market volume is 65 bln MDUs, with the dynamics of +2.8%.

5/15/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Only 17% of Doctors in Russia Undergo Regular Testing for COVID-19

36% of doctors say that no COVID-19 testing is conducted in the hospitals where they work, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

5/7/2020 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (March and Q1 2020)

Between January and March 2020, Russia imported 262 thousand units of pharmaceutical drugs for clinical trials (CT), worth 6 bln RUB (customs clearance prices, VAT included). The dynamics in both monetary (rubles) and physical terms (units) are +56%. The number of imported trademarks has risen from 320 to 386. The number of placebo drugs has grown from 109 to 139 trademarks. In physical terms, placebos account for around 30% of the import (against 46% in 2019), while in monetary terms it is 21.7% (nearly the same as in 2019).

5/7/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 63% of Doctors Believe that Incidence of COVID-19 in Russia will not Begin Decreasing until Summer

Only 7% of doctors think that the incidence of coronavirus infection in Russia will start declining as early as mid-May, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

4/30/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 71% of Russian Doctors Report Serious Problems with Providing Healthcare Facilities with Personal Protective Equipment (PPE)

Only 8% of Russian doctors say that the healthcare facilities they work in provide all the necessary personal protective equipment, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 17% say that there have been some interruptions in the provision, but the situation is not critical in general.